MULTIPLE SCLEROSIS, RELAPSING

Clinical trials for MULTIPLE SCLEROSIS, RELAPSING explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE SCLEROSIS, RELAPSING trials appear

Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, RELAPSING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Landmark study tests MS drug in underrepresented patient groups

Disease control Completed

This study looked at how well the approved MS drug ocrelizumab works to control disease activity in Black and Hispanic patients with relapsing multiple sclerosis. Researchers followed 179 patients for 48 weeks to see if the treatment prevented relapses, disability progression, or…

Matched conditions: MULTIPLE SCLEROSIS, RELAPSING

Phase: PHASE4 • Sponsor: Genentech, Inc. • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

MULTIPLE SCLEROSIS, RELAPSING

Get alerted when new MULTIPLE SCLEROSIS, RELAPSING trials appear

Landmark study tests MS drug in underrepresented patient groups